Blog

Testosterone Supplements Require Further Testing, FDA Declares

Testosterone supplements have been approved by the Food and Drug Administration (FDA) to treat only certain, and relatively rare, medical conditions that slow or halt natural production of the hormone ...
Continue reading "Testosterone Supplements Require Further Testing, FDA Declares" »

FDA Issues Warning About Using Testosterone Products; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke

The FDA today released the following safety alert on its website. Please contact us immediately if you have been using testosterone products for low testosterone due to aging and have experienced any ...
Continue reading "FDA Issues Warning About Using Testosterone Products; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke" »

FDA Advised to Restrict Testosterone Prescriptions

An expert panel made up of two advisory committees has voted overwhelmingly for the FDA to impose strict new limitations on the multi-billion dollar testosterone drug industry. It was recommended that ...
Continue reading "FDA Advised to Restrict Testosterone Prescriptions" »

FDA Meets to Assess Low-T Health Risks

If you are currently or considering undergoing testosterone replacement therapy, stay tuned. In a combined meeting with two advisory committees, the FDA will be spending today and tomorrow assessing ...
Continue reading "FDA Meets to Assess Low-T Health Risks" »

David Ratner Appointed to Low-T MDL Trial Committee

David Ratner, Managing Partner of Morelli Law Firm, has been selected to serve as a member of the Multidistrict Litigation (MDL) Trial Committee for the litigation against testosterone replacement ...
Continue reading "David Ratner Appointed to Low-T MDL Trial Committee" »

New Feature Story on Low-T in Time Magazine

In big red letters across the front cover of this month's issue of Time Magazine are the words Manopause? Aging, Insecurity and the $2 Billion Testosterone Industry. The feature article ...
Continue reading "New Feature Story on Low-T in Time Magazine" »

David Ratner Re-Elected as Co-Chair of AAJ's Testosterone Therapy Litigation Group

David Ratner, Managing Partner of Morelli Law Firm, LLP, was re-elected today as co-chair of the American Association of Justice's Testosterone Therapy litigation group. In this capacity, Mr. ...
Continue reading "David Ratner Re-Elected as Co-Chair of AAJ's Testosterone Therapy Litigation Group" »

FDA Unwilling to Include Black Box Warnings on Testosterone Replacement Therapy Drugs

The US Food and Drug Administration denied a citizen petition Wednesday from advocacy group Public Citizen demanding the agency to notify consumers of possible cardiovascular risks stemming from use ...
Continue reading "FDA Unwilling to Include Black Box Warnings on Testosterone Replacement Therapy Drugs" »

JPML Creates All Testosterone Product MDL

On June 6, 2014, the Judicial Panel on Multidistrict Litigation (JPML) created an all testosterone product MDL in the Northern District of Illinois before Judge Kennelly. This decision was made on the ...
Continue reading "JPML Creates All Testosterone Product MDL" »

FDA Adding General Warning About Venous Blood Clotting to Testosterone Products

The FDA announced that it is requiring a general warning in the drug labeling for all approved testosterone products about the potential risk of venous thromboembolism (VTE), or blood clots in the ...
Continue reading "FDA Adding General Warning About Venous Blood Clotting to Testosterone Products" »

Europe to Review Testosterone Safety

Last week, the European Medicines Agency announced plans to investigate the safety of testosterone drugs. The announcement came in response to the recent study from PLoS One, which found an increase ...
Continue reading "Europe to Review Testosterone Safety" »

Morelli Law Firm Moves to Coordinate Actions

On March 18, 2014, the United States District Court for the Northern District of Illinois granted a motion to coordinate actions among all AndroGel cases. The granting of this motion, which was filed ...
Continue reading "Morelli Law Firm Moves to Coordinate Actions" »

Low-T "Ghost Writer" Comes Clean

In recent years, efforts have been made to limit the abuses of pharmaceutical influence and encourage greater transparency in medical communications. According to medical writer Stephen Braun, these ...
Continue reading "Low-T "Ghost Writer" Comes Clean" »

Dr. John La Puma Warns Against Asking Your Doctor About 'Low T'

In the New York Times Op-Ed "Don't Ask Your Doctor About 'Low T," Dr. John La Puma addresses the over-prescription of testosterone supplements that has occurred during the last ...
Continue reading "Dr. John La Puma Warns Against Asking Your Doctor About 'Low T'" »

Prominent Consumer Advocacy Group Calls for FDA to Implement Stronger Labeling Requirements for Testosterone Drugs

Public Citizen, a prominent consumer advocacy group, has called on the Food and Drug Administration (FDA) to require drug manufacturers to add a bold warning label, also known as a "black ...
Continue reading "Prominent Consumer Advocacy Group Calls for FDA to Implement Stronger Labeling Requirements for Testosterone Drugs" »

PLOS One Study Finds Increased Risk of Heart Attack Following Testosterone Treatment

Earlier this year, the Public Library of Science (PLOS One) published findings from a study examining men who used testosterone products like AndroGel® . The study examined over 55,000 men who ...
Continue reading "PLOS One Study Finds Increased Risk of Heart Attack Following Testosterone Treatment" »

Morelli Alters Ratner LLP First to File AndroGel® Lawsuits

On Tuesday, February 4, 2014, Morelli Law Firm LLP filed complaints against Abbott Laboratories Inc. and AbbVie Inc. on behalf of five men who suffered severe cardiovascular injuries. These injuries ...
Continue reading "Morelli Alters Ratner LLP First to File AndroGel® Lawsuits" »
Call Us Today (888) 396-4930